Elli Kaplan founded Neurotrack in 2012 with a breakthrough non-invasive cognitive diagnostics test that will detect Alzheimer's Disease in its earliest pre-symptomatic stages. While the company has gained great traction in the three years since it was started, with no therapeutic product available in the foreseeable future Kaplan is considering whether it is time to change the company's business model.

【書誌情報】

ページ数：22ページ

サイズ：A4

商品番号：HBSP-816072

発行日：2016/2/15

登録日：2017/6/5